Bristol-Myers Squibb Co. (BMY) Shares Rise 3.76% on February 6

Bristol-Myers Squibb Co (BMY) shares surged 3.76% on Feb 6, reaching an intraday high of $62.00 and settling at $61.76. Trading volume was 6,485,519 shares, 45.1% of the average daily volume. Based on 25 analysts' one-year price targets, the average target is $57.56 with a high estimate of $68.00 and a low estimate of $33.10, indicating a 6.80% downside from the current price. The average brokerage recommendation is 2.5, indicating "Outperform" status. The estimated GF Value for Bristol-Myers Squibb Co in one year is $51.34, suggesting a 16.87% downside from the current price.